250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device VC (Venture Capital) Funds in Switzerland in April 2025

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Switzerland. We rank investors based on the number of investments they made in Medical device companies from Switzerland. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Switzerland in April 2025

Investor Medical Device Switzerland investments
Zürcher Kantonal Bank 24
Foundation for Innovation and Technology (FIT) 14
Verve Ventures 13
VI Partners 9
StartAngels Network 7
redalpine 5
OCCIDENT 5
BioMedPartners 5
Translink Capital 4
Zühlke Ventures AG 4
4FO Ventures 4
Alpana Ventures 3
Neomed Management 3
M Ventures 3
Innosuisse 3
BlueOcean Ventures 3
EIT Health 3
Fongit Seed Invest 3
415 Capital 3
EVA Basel 3
3wVentures 3
Kinled Holding 2
Initiative Capital Romandie 2
SICTIC 2
New Enterprise Associates 2
TiVentures 2
Swisscom Ventures 2
Schroder Adveq 2
Inkef 2
Polytech Ventures 2
Molten Ventures 2
VitaTech S.A 2
Sofinnova Partners 2
Khosla Ventures 1
Astanor Ventures 1
HBM Partners 1
High-Tech Gruenderfonds 1
Steyn Group 1
Kickfund 1
BB Biotech Ventures 1
NV Capital 1
TR Invest 1
Supermoon Capital 1
Swiss Diabetes Venture Fund 1
AA Sons 1
Privilège Ventures 1
LabCorp Venture Fund 1
Technology Fund 1
Spicehaus Partners 1
N&V Capital 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Zürcher Kantonal Bank VC Fund · Zürich, Zurich, Switzerland · 13 investments in the past 12 months
Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Series A, Funding Round
  • Switzerland, Japan, Spain
Portfolio highlights
  • DPhi Space — DPhi Space is a startup that specializes in shared satellites for hosted payloads to simplify access to space. The company's flagship product, Clustergate, is a modular platform that aggregates multiple payloads—such as sensors, antennas, or cameras—into a single container, allowing them to share a satellite. This approach reduces costs andcomplexity by optimizing satellite resources. Clustergate offers built-in in-orbit computing, AI processing, and real-time data analytics, enabling businesses to deploy and manage their technology in space without requiring specialized expertise.
  • Retinai — RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Foundation for Innovation and Technology (FIT) VC Fund · Lausanne, Vaud, Switzerland · 8 investments in the past 12 months
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Debt Financing, Grant, Seed
  • Switzerland, France
Portfolio highlights
  • Aspivix — ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
  • Xemperia — Xemperia provides diagnostic solutions that helps to detect breast cancer and early diagnosis of relapses.
  • Ex Nunc Intelligence — Ex Nunc Intelligence provides professionals with thorough summaries of legal information, credible responses to legal issues, and automated legal document preparation features.
Verve Ventures VC Fund · Zug, Zug, Switzerland · 18 investments in the past 12 months
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, France, Germany
Portfolio highlights
  • tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
  • Metafuels — Our breakthrough sustainable aviation fuel (SAF) technology, aerobrew™, will make affordable net-zero aviation a reality. The technology is innovative, highly scaleable and able to tap into future global renewable energy systems efficiently. Starting from renewable feedstocks including green hydrogen, driven by renewable electricity, andsustainably sourced CO2, for example from direct air capture, aerobrew™ provides an efficient route to large-scale production of e-kerosene, overcoming the scale up challenges and high costs of alternative e-fuels technologies. aerobrew™ is also compatible with the biogenic route whereby the carbon required for the process is derived from renewable and sustainable cellulosic biomass which, does not compete with the food chain (wood, miscanthus, etc.). With a high carbon conversion, high selectivity and a high overall SAF yield, aerobrew™ leads to attractive production economics and cost leadership. With a rapidly growing demand for SAF, aerobrew™ stands to contribute significantly to the decarbonisation of global aviation and to support the achievement of net zero 2050 targets.
  • Orakl Oncology — Cultivated with love by the Orakl team.
VI Partners VC Fund · Altendorf, Schwyz, Switzerland · 9 investments in the past 12 months
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • Switzerland, Germany, United States
Portfolio highlights
  • Kadoa — AI-Powered Web Scraping Automation | No-Code, Maintenance-Free Data Extraction & Transformation
  • Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
  • Unique — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.
StartAngels Network VC Fund · Zürich, Zurich, Switzerland
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Seed, Series A, Series B
  • Switzerland, Brazil
Portfolio highlights
  • Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
  • Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
redalpine VC Fund · Zürich, Zurich, Switzerland · 12 investments in the past 12 months
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Series A, Seed, Series B
  • Germany, Switzerland, United Kingdom
Portfolio highlights
  • 9fin — 9fin is a leading provider of debt market intelligence and offers everything you need to analyse a credit, or win a mandate in one AI-powered platform
  • Apaleo — Transform your hospitality business with an open platform. Easily connect 3rd party applications to build a best-in-class tech stack for your hotel
  • OrthoPulse — OrthoPulse is a medical device manufacturer that produces dental care equipment, treatment control apps, and photo biomodulation solutions.
OCCIDENT VC Fund · Zug, Zug, Switzerland
Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Series B, Series C
  • Germany, Switzerland, Slovenia
Portfolio highlights
  • ReCatalyst — REvolutionizing the way we make CATALYSTs for hydrogen technologies
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
BioMedPartners VC Fund · Basel, Basel-Stadt, Switzerland
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Switzerland, Germany, France
Portfolio highlights
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
  • TOLREMO therapeutics — TOLREMO therapeutics is striving to prevent the development of cancer therapy resistance through its proprietary drug discovery and development platform. Learn more about us.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Zühlke Ventures AG VC Fund · Schlieren, Zurich, Switzerland
Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, Sweden, United States
Portfolio highlights
  • Evismo — Evismo provides diagnostics services in Switzerland
  • Healios AG — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
  • Flow Neuroscience — Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of thebrain that has often lowered activity in people suffering from depression.Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry.
4FO Ventures VC Fund · Luxembourg, Luxembourg, Luxembourg
4FO Ventures
Show more
Investment focus
  • Artificial Intelligence, Health Care, Medical
  • Series A, Seed, Series B
  • Switzerland
Portfolio highlights
  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
  • ARTIRIA Medical — Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
Alpana Ventures VC Fund · Geneva, Geneve, Switzerland
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more
Investment focus
  • Software, FinTech, Information Technology
  • Seed, Series A, Funding Round
  • United States, Switzerland, Germany
Portfolio highlights
  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
  • Tinamu — Tinamu Labs has developed a technology that converts commercially available drones into camera equipment reaching professional standards.
Neomed Management VC Fund · Oslo, Oslo, Norway
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series C, Funding Round
  • Switzerland, United States, Italy
Portfolio highlights
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
  • JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 16 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
  • NovoLINC — NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
  • TRIMTECH Therapeutics — TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
Innosuisse VC Fund · Berne, Bern, Switzerland · 9 investments in the past 12 months
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Grant, Pre-Seed, Seed
  • Switzerland, United States, United Kingdom
Portfolio highlights
  • Vestir AI — We're revolutionizing online clothes shopping through AI-powered digital avatar technology. In 3D, in video, with photo-likeness & garment movement - further than anyone has attempted before. Our mission is to recreate the in-store fitting room experience online, changing online shopping forever.
  • Ymmunobio — At Ymmunobio, our research is based on our deep understanding of immuno-oncology and precision cancer treatments. We leverage our profound knowledge of biologics, focusing on unique and first-in-class targets while selecting the optimal approach to developing transformative therapeutics across cancer indications.
  • Csky.ai — A unique, private-by-design solution for secure transcription, automated note-taking, compliant reporting, and more. With on-device AI, your data never leaves the room.
BlueOcean Ventures VC Fund · Plan-les-ouates, Geneve, Switzerland
BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, India, France
Portfolio highlights
  • nPloy — Simply set your filters and get matched with your dream job! Let top employers apply for you & connect with them via chat or a video call.
  • CyanoGuard AG — Our award-winning cyanide testing and optimizing solution is ideal for the mining, food, and medical field. It's easy to use, digital and offers real-time data.
  • 99RetailStreet — 99RetailStreet is an eCommerce Cloudplatform for the unorganized Retail business in the developing countries. Our ecosystem targets Retailers, Distributors, and Manufacturers. 99RetailStreet provides POS solutions to Retailers, Real-Time Analytics to Manufacturers and Distributors
EIT Health VC Fund · Munich, Bayern, Germany
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Grant, Pre-Seed, Seed
  • United Kingdom, Spain, Ireland
Portfolio highlights
  • IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
  • eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Fongit Seed Invest VC Fund · Plan-les-ouates, Geneve, Switzerland
Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • Switzerland
Portfolio highlights
  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
415 Capital VC Fund · Oberhaching, Bayern, Germany
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcaresystem.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Series A, Series C, Seed
  • Switzerland, United States, France
Portfolio highlights
  • Aktiia — Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.
  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
EVA Basel VC Fund · Basel, Basel-Stadt, Switzerland
EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.
Show more
Investment focus
  • Biotechnology, Medical Device, Medical
  • Seed, Series A
  • Switzerland
Portfolio highlights
  • AOT - Advanced Osteotomy Tools — AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser,robotics and navigation systems to re-invent bone surgery (osteotomy).
  • POLYNEURON — Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patientswith immune disorders in a safe and effective manner.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
3wVentures VC Fund · Herisau, Ausser-Rhoden, Switzerland
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Angel, Series A
  • Switzerland, Spain, Austria
Portfolio highlights
  • Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
  • GUURU — GUURU's Community Solution enables trustworthy and authentic live conversations between shoppers and your customer community.
  • Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Kinled Holding VC Fund · New York, New York, United States
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more
Investment focus
  • Biotechnology, Health Care, Financial Services
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Switzerland
Portfolio highlights
  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
  • Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Initiative Capital Romandie VC Fund
Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Series E
  • Switzerland
Portfolio highlights
  • PicoDRILL — PicoDRILL generates technology leadership for its partner/customers through cutting-edge technology for drilling needs in the nanotechnology field. picoDrill is a private company located in Lausanne, Switzerland.
  • Diagnoplex — Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rüf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as wellas its high sensitivity and specificity.
  • Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.
SICTIC VC Fund · Zürich, Zurich, Switzerland · 5 investments in the past 12 months
Swiss ICT Investor Club (SICTIC) connects smart money investors to Swiss seed and early-stage tech startups.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Funding Round
  • Switzerland, Germany, United Kingdom
Portfolio highlights
  • Pelt8 — Pelt8 enables climate action through the platform with scalable processes and controls to collect sustainability-related data in an easy and traceable way.
  • Nextesy — Nextesy is a pioneering start-up that uses AI to simplify and automate important business processes, allowing businesses to alleviate the strain of repetitive manual procedures while increasing operational efficiency and scalability.
  • Insurteam — Insurteam provides the benefits of its technology to all insurance companies that service the travel and leisure sector.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 54 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, Canada
Portfolio highlights
  • Ceramic.ai — Ceramic.ai builds enterprise-grade infrastructure to optimize how companies train and deploy their AI models
  • Vori Health — Meet Vori Health, the new virtual and in-person musculoskeletal healthcare company that will help you get that spring back into your step.
  • Ceramic — Next generation AI training systems for better models with less compute, less time, and lower costs.
TiVentures VC Fund · Lugano, Ticino, Switzerland
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more
Investment focus
  • Software, Analytics, Renewable Energy
  • Seed, Series A, Funding Round
  • Switzerland, Italy, United States
Portfolio highlights
  • Hoxell — Hoxell is an intuitive and easy-to-use integrated platform that digitizes and streamlines all hospitality operations.
  • Hive Power — Hive Power provides a SaaS platform to optimise your existing electrical distribution grid, both from the technical and economic points of view.
  • Gaia Turbine — Gaia Turbine SA - High-Performance Hydroelectric Turbine for micro and mini power plants
Swisscom Ventures VC Fund · Zürich, Zurich, Switzerland · 4 investments in the past 12 months
Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Funding Round, Series B, Series A
  • Switzerland, United States, United Kingdom
Portfolio highlights
  • ANYbotics — ANYbotics provides autonomous legged robots for industrial applications to provide high availability and reliability in automated routine inspections.
  • Kyan Health — Prioritise your employees' mental health and well-being with Kyan Health. Our evidence-based solutions address employees' mental well-being, stress at work & boost your workforce productivity.
  • Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Schroder Adveq VC Fund · Zürich, Zurich, Switzerland
Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series C, Series A
  • Switzerland, United States, India
Portfolio highlights
  • Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
  • Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399, all this while you sit in the comfort of your home. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able todo in India yet.The website has over 500 designs of eye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery.Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision are to name a few) and be it disposable, toric, colored or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Inkef VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in the past 12 months
SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • The Netherlands, United States, Germany
Portfolio highlights
  • Onward — Working to restore movement, independence, and health in people with spinal cord injury.
  • Draupnir Bio — Draupnir Bio is developing new innovative therapies for patients.
  • Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
Polytech Ventures VC Fund · Lausanne, Vaud, Switzerland
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more
Investment focus
  • Financial Services, FinTech, Software
  • Seed, Series A, Funding Round
  • Switzerland, United States, Spain
Portfolio highlights
  • yamo — Frische Bio-Kindernahrung von yamo, so lecker wie selbstgemacht und kostenlos direkt zu dir nach Hause geliefert. Jetzt probieren und profitieren.
  • Relai — Relai is the easiest way to invest in Bitcoin for the long-term investor. A simple and intuitive app that allows users to buy and sell Bitcoin directly from their bank account within 1 minute, without registration, KYC verification or deposits. It was founded in 2019 and is headquartered in Zurich, Switzerland.
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Molten Ventures VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
Molten Ventures is a venture capital company. They invest in software, telecoms, electronics, the internet, MedTech, and cleantech services. They support visionary entrepreneurs who will invent the future.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Series A, Series B, Funding Round
  • United Kingdom, United States, Germany
Portfolio highlights
  • PocDoc — PocDoc is a pioneer in the field of smartphone-based fast disease testing.
  • Sightline Climate — A market intelligence platform bringing clarity to the new climate economy.
  • SatVu — SatVu captures high resolution thermal data from space for a safer and more sustainable Earth.
VitaTech S.A VC Fund
VitaTech S.A
Show more
Investment focus
  • Medical Device, Biotechnology, Therapeutics
  • Series A
  • Switzerland, United States
Portfolio highlights
  • Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
  • Gain Therapeutics — Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
  • Industrie Biomediche Insubri — IBI is an innovative hi-tech Swiss biomedical company focused on research, development and production of medical devices for tissue engineering and regenerative medicine: substitutes, grafts, 3D matrixes and 2D scaffolds.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 19 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Berry Street — Nutrition therapy by registered dietitians covered by insurance.
Khosla Ventures VC Fund · Menlo Park, California, United States · 62 investments in the past 12 months
Khosla Ventures invests in companies that are bold, early, and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs.Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech, digital health, medtech anddiagnostics, therapeutics, and frontier technology.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, India, United Kingdom
Portfolio highlights
  • Jones — Jones is a software company that rebuilt liability management for real estate companies who want do less and get more – much more. We are solving one of the most archaic and outdated processes in commercial real estate - insurance certificates. For owners, managers and developers who need to solve insurance compliance for everyone in the valuechain, Jones is the simplest solution ever made.
  • Basis — Basis operates as an AI platform built specifically for accounting firms.
  • Clear Labs — Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics, and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity.Clear Labs’ turnkeyplatform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS CoV-2. With a novel approach, Clear Labs is helping the world better understand, track, and mitigate tomorrow’s novel pathogens.
Astanor Ventures VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 8 investments in the past 12 months
Astanor Ventures is a venture capital firm focusing on entrepreneurs regenerating the food, blue ocean economy, and agriculture sector. The firm targeting technology-enabled companies across the agri-food value chain, leveraging disruptive technologies to bring about a future of food that is nourishing, regenerative, trusted, and ultra-fresh. Itrings together capital, deep sector knowledge, and a strong network of entrepreneurs, impact investors, technologists, scientists, farmers, chefs, policymakers, and food lovers to give rise to a future of food that is nourishing, regenerative, scalable, trusted, and delicious.
Show more
Investment focus
  • Agriculture, Biotechnology, Food and Beverage
  • Series A, Seed, Series B
  • United States, France, United Kingdom
Portfolio highlights
  • Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
  • Holobiome — Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety, and other mental health problems including our metabolism and the immune response,enabling patients to recover quickly from their diseases easily without any pain and suffering.Holobiome was established in 2015 and is based in Cambridge, Massachusetts.
  • Plantible Foods — We are developing the best tasting and most functional, sustainable plant-based protein by using lemna, also known as duckweed
HBM Partners VC Fund · Zug, Zug, Switzerland
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series B, Funding Round, Series C
  • United States, Germany, Switzerland
Portfolio highlights
  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
  • Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
High-Tech Gruenderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 47 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • AICA SA — AICA believes programming robots should be at everyone's reach. We combine Artificial Intelligence & an intuitive interface, to help you relocate your production.
  • ctrl+s — High resolution insights into the deep supply chain are the building blocks for every substantive sustainability strategy and effective decarbonization.
  • Akribion Genomics — Specific, versatile, effective RNA-guided cell depletion
Steyn Group VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Steyn Group is a global single family office platform that specializes in private market investments. We provide infrastructure and zero time preference capital to support emerging investment managers and businesses.
Show more
Investment focus
  • Advice, Hospital, CleanTech
  • Seed, Series A, Series B
  • United Kingdom, Switzerland, South Africa
Portfolio highlights
  • Bio-Logical — Bio-Logical offers technology to sequester carbon from agricultural waste and transform it into, climate resilience building fertiliser. This innovation is more than a product; it's a promise to regenerate land, dramatically boost crop yields, and tackle climate change head-on.
  • Enko Education — [mk_page_section bg_image="https://enkoeducation.com/wp-content/uploads/2021/03/cnp-enko-399.jpg" blend_mode="darken" bg_position="center center" bg_repeat="no-repeat" bg_stretch="true" video_color_mask="#0a0a0a" video_opacity="0.3" min_height="0" pa...
  • Carbon Capture Scotland — Carbon Capture Scotland seeks to get rid of carbon dioxide that has been organically stored in grains and barley.
Kickfund VC Fund · Basel, Basel-Stadt, Switzerland · 13 investments in the past 12 months
Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.
Show more
Investment focus
  • Renewable Energy, Biotechnology, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • Switzerland
Portfolio highlights
  • qCella — qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires. When linked to a power source (e.g., a battery), the mats have the right electrical resistance over the entire structure, allowing them to heat uniformly.
  • DPhi Space — DPhi Space is a startup that specializes in shared satellites for hosted payloads to simplify access to space. The company's flagship product, Clustergate, is a modular platform that aggregates multiple payloads—such as sensors, antennas, or cameras—into a single container, allowing them to share a satellite. This approach reduces costs andcomplexity by optimizing satellite resources. Clustergate offers built-in in-orbit computing, AI processing, and real-time data analytics, enabling businesses to deploy and manage their technology in space without requiring specialized expertise.
  • SolidWatts — We electrify industrial process heating by creating the new state-of-the-art in microwave and radio frequency power sources for industry.
BB Biotech Ventures VC Fund · Zürich, Zurich, Switzerland
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated teamof investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series C, Series A, Funding Round
  • United States, Switzerland, Italy
Portfolio highlights
  • Arvinas — Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.
NV Capital VC Fund
N & V Capital is a family-owned venture capital boutique focused on European investments. With generations of entrepreneurial experience, we seek scalable ventures driven by technology or scientific progress.
Show more
Investment focus
  • Wellness, Health Care, Medical Device
  • Series A
  • Switzerland
Portfolio highlights
  • Odne — Curing with light
TR Invest VC Fund · Tafers, Fribourg, Switzerland
Private Investment Company
Show more
Investment focus
  • Manufacturing, Software, Apps
  • Funding Round, Seed, Series A
  • Switzerland, Spain, Sweden
Portfolio highlights
  • CompPair — CompPair is an EPFL spin-off solving damage issues for the composite materials industry by developping smart sustainable textiles.
  • Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
  • Fidentity — Fidentity wants to inject trust from the real world into online interactions.
Supermoon Capital VC Fund · San Francisco, California, United States
Supermoon Capital is a specialist platform helping visionary founders enhance our lives, organizations, and communities through healthy sleep.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical Device
  • Seed, Series A, Funding Round
  • Switzerland, United States, Israel
Portfolio highlights
  • Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
  • Arcascope — We create mobile apps based in circadian science to help people sleep and feel better.
  • Mosanna Therapeutics — Improving the lives of patients with metabolic obstructive sleep apnea using a transformative approach
Swiss Diabetes Venture Fund VC Fund · Lausanne, Vaud, Switzerland
Swiss Diabetes Venture Fund is europe’s first venture fund dedicated to diabetes technology.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Norway, Sweden, Switzerland
Portfolio highlights
  • Piomic — There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg andfoot ulcers.The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life. The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.By developing a therapy which is safe and effective we hope to set a better future for patients in need.
  • GlucoSet — GlucoSet develops tools for accurate continuous glucose monitoring in Intensive Care Units, to reduce patient mortality and hospital costs.
  • BOYDSenseBOYDSense SAS — BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronicdiseases.It was founded in 2015 and headquartered in South San Francisco, California.
AA Sons VC Fund · London, England, United Kingdom
AA Sons focuses on raising venture capital for ambitious, fast-growing companies with a desire to 'make the world a better place' in retail, mobility, healthcare, care, fintech and broader tech sectors.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Funding Round
  • France, United States, Israel
Portfolio highlights
  • HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
  • Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
  • Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.
Privilège Ventures VC Fund · Zürich, Zurich, Switzerland
Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team
Show more
Investment focus
  • Health Care, Hardware, Software
  • Seed, Series A, Funding Round
  • Switzerland, France
Portfolio highlights
  • Wyth — Wyth makes technologies that help humans create meaningful relationships by bringing emotions, stories and connections beyond the interface.
  • Smeetz — Smeetz is the future of a unified, data-driven and dynamic pricing-oriented commerce for attractions and cultural venues.
  • Avelo — Our mission is to save lives by bringing fast and actionable infectious disease diagnosis closer to the patient. Avelo's solution is a breath collection device. It works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia
LabCorp Venture Fund VC Fund · Burlington, North Carolina, United States
LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces and developing novel solutions to important problems in health and healthcare.Investments are typically early stage (Series A or Series B). LabCorp’s typical initial investment is $500K-$2M, reserving up to $5M for follow-oninvestment. LabCorp typically does not lead financing rounds, but prefers to co-invest with an institutional or strategic lead.
Show more
Investment focus
  • Medical, Wearables, Health Care
  • Funding Round, Seed, Series B
  • United States, Switzerland
Portfolio highlights
  • AOA — AOA based in Boston, New York, and London developing cancer diagnostics in the field of women’s health.AOA is a female-led company, is committed to bringing the first accurate early-stage liquid biopsy ovarian cancer diagnostic test to market that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.
  • Biospectal — Biospectal is the remote patient monitoring and biosensing software company, developed the OptiBP smartphone app and data platform to empower people worldwide with a medical-grade device integrated directly into their smartphone for instantaneous blood pressure measurement and monitoring, anytime and anywhere. The app runs on a typical smartphoneand uses the built-in camera to record and measure a user’s blood flow via their fingertip quickly and easily. A measurement is rendered in approximately 20 seconds — half the time of a typical blood pressure cuff. The company’s proprietary algorithms and optical signal capture methods then transform the captured data into blood pressure values. The Biospectal OptiBP for Android public beta is available now in the US, UK, France, Germany, Spain and Switzerland.
  • Circuit Clinical — Circuit Clinical was born from the experiences of a physician conducting clinical research in his busy private practice. From the core belief that patients prefer to learn about clinical research from healthcare providers they trust, came the vision for Circuit Clinical Since 2015 we've built one of the largest Integrated ResearchOrganizations [IRO] in the US. Our focus on physician and participant engagement gives us a distinct advantage with identification of motivated participants through direct HIPAA/FDA-compliant Electronic Medical Record (EMR) review. Coupled with our technology products that enhance the participant and physician experience, Circuit Clinical provides our network of more than 1 million patients, our physicians, and our sponsor partners a new path forward in clinical research.
Technology Fund VC Fund · Zürich, Zurich, Switzerland · 7 investments in the past 12 months
Technology Fund offers loan guarantees to Swiss companies whose novel products contribute to a sustainable reduction in greenhouse gas emissions
Show more
Investment focus
  • Software, Energy, Information Technology
  • Debt Financing, Grant, Seed
  • Switzerland, Italy, Germany
Portfolio highlights
  • Distran — Distran ultrasonic cameras detect leaks of any type of gas in industrial facilities at a distance with live leak rate quantification. ATEX-certified.
  • Solaxess — Solaxess SA was established in January 2015 by the two founders domiciled in Neuchatel, Sebastien Eberhard and Olivier Gavillet. This allows us to keep the technology, which was developed by CSEM, in Switzerland. They operate internationally, headquartered in Neuchatel - Switzerland.They deploy 3 patents of the CSEM to manufacture andcommercialize a nanotechnology based film for the use in Photovoltaic modules in order to render them in different surface colors. Especially white, which is a uniqueness in the market.
  • Bionomous — Bionomous - the world's first provider of AI-powered solutions for screening, sorting and dispensing of small biological entities. We are an innovative, agile
Spicehaus Partners VC Fund · Zug, Zug, Switzerland · 4 investments in the past 12 months
Venture Capital made in Switzerland Who we are Strong Investment Portfolio 40 companies funded Our portfolio Driving digital transformation By backing successful founders Our approach 01 We drive digital transformation in Switzerland Spicehaus Partners AG is an independent Swiss venture capital investor, fully owned by its partners. We focus on early-stage companies in the technology
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Funding Round, Series A
  • Switzerland
Portfolio highlights
  • Caplena — Enabling brands & market research agencies to discover insights by combining open-ended text with quantitative variables.
  • DAAV — At DAAV we are working on providing mobility services for people with reduced mobility in indoor environments.
  • Drone Harmony AG — Drone Harmony was founded in 2016 by a team of problem solvers with a passion for drones, software and automation. From their very early days, they have set out to tackle the mathematical and engineering challenges of enabling cost-effective deployment of drone technology in industries, where existing technologies were unable to deliver.DroneHarmony reinvents the way people fly drones commercially. Its 3D flight planning software turns anyone with a drone into an inspection professional. Sophisticated algorithms reduce complex industrial inspection tasks to automated and scalable workflows.
N&V Capital VC Fund · Vaduz, Vaduz, Liechtenstein · 4 investments in the past 12 months
N & V Capital is a family-owned venture capital boutique focused on European investments. With generations of entrepreneurial experience, we seek scalable ventures driven by technology or scientific progress. We engage primarily up to Series A rounds, preferring early-stage involvement to support visionary founders aiming for sustainablegrowth. Our commitment is for the long term, and we are driven by pragmatism, open-mindedness, and hands-on assistance wherever required.
Show more
Investment focus
  • Health Care, Leasing, Medical
  • Seed, Pre-Seed, Series A
  • Germany, Switzerland
Portfolio highlights
  • LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
  • Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
  • Virtonomy GmbH — Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Switzerland by industry